Laboratory diagnosis of COVID-19
Objectives: This was a non-systematic review of the literature on the laboratory diagnosis of COVID-19. Data sources: Searches in PubMed and Google Scholar for articles made available in 2020, using the terms diagnosis ¨ OR¨ diagnostic’’ ¨ OR diagnostic ¨ testsOR¨ ¨testsAND ¨ COVID-19 ¨ OR¨ ¨SARS-Co...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12728
- Acceso en línea:
- https://doi.org/10.1016/j.jped.2020.08.001
http://hdl.handle.net/20.500.12010/12728
- Palabra clave:
- Diagnosis
Diagnostic tests
Diagnostic techniques and procedures
COVID-19
Coronavirus
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)
Summary: | Objectives: This was a non-systematic review of the literature on the laboratory diagnosis of COVID-19. Data sources: Searches in PubMed and Google Scholar for articles made available in 2020, using the terms diagnosis ¨ OR¨ diagnostic’’ ¨ OR diagnostic ¨ testsOR¨ ¨testsAND ¨ COVID-19 ¨ OR¨ ¨SARS-CoV-2¨in the title. Summary of findings: Tests for the etiological agent identify genetic material of SARS-CoV-2 or humoral responses to it. The gold standard for diagnosis is the identification of viral genome targets by real-time polymerase chain reaction (RT-PCR) in respiratory tract materials during the first week of symptoms. Serological tests should be indicated from the second week of symptoms onwards. A wide range of different tests is available, with variable sensitivity and specificity, most of which require validation. Laboratory tests such as complete blood count, C-reactive protein (CRP), D-dimer, clotting tests, lactic dehydrogenase (LDH), ferritin, and procalcitonin identify risk of disease with greater severity, thromboembolic complications, myocardial damage, and/or worse prognosis. Imaging tests may be useful for diagnosis, especially when there is a compatible clinical picture, and other tests presented negative results or were unavailable. Conclusions: The identification of genetic material of the virus by RT-PCR is the gold standard test, but its sensitivity is not satisfactory. The diagnosis of COVID-19 should be based on clinical data, epidemiological history, tests for etiological diagnosis, and tests to support the diagnosis of the disease and/or its complications. New diagnostic methods with higher sensitivity and specificity, as well as faster results, are necessary. © 2020 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/ 4.0/). |
---|